Simultaneous Quantification of Mesalamine and Its Metabolite N-Acetyl Mesalamine in Human Plasma by LC-MS/MS and Its Application to a Bioequivalence Study

References (34)

1. 1 High-performance liquid-chromatographic determination of 5-aminosalicylic acid and its metabolites in blood plasma [DOI]
2. 2 Development and validation of a HPLC-ESI-MS/MS method for the determination of 5-aminosalicylic acid and its major metabolite N-acetyl-5-aminosalicylic acid in human plasma [DOI]
3. 3 Determination of 5-aminosalicylic acid in pharmaceutical formulation by differential pulse voltammetry [DOI]
4. 4 Determination of sulphasalazine and its main metabolite sulphapyridine and 5-aminosalicylic acid in human plasma by liquid chromatography/tandem mass spectrometry and its application to a pharmacokinetic study [DOI]
5. 5 Quantitative HPLC analysis of mebeverine, mesalazine, sulphasalazine and dispersible aspirin stored in a Venalink monitored dosage system with co-prescribed medicines [DOI]
6. 6 Simple method for the determination of 5-aminosalicylic and N-acetyl-5-aminosalicylic acid in rectal tissue biopsies [DOI]
7. 7 5-Aminosalicylic Acid in a Slow-Release Preparation: Bioavailability, Plasma Level, and Excretion in Humans [DOI]
8. 8 A validated HPLC method with electrochemical detection for simultaneous assay of 5‐aminosalicylic acid and its metabolite in human plasma [DOI]
9. 9 Simultaneous determination of 5-aminosalicylic acid, acetyl-5-aminosalicylic acid and 2,5-dihydroxybenzoic acid in endoscopie intestinal biopsy samples in humans by high-performance liquid chromatography with electrochemical detection [DOI]
10. 10 Validation of a LC method for the determination of 5-aminosalicylic acid and its metabolite in plasma and urine [DOI]
11. 11 Comparative bioavailability of 5‐aminosalicylic acid from a controlled release preparation and an azo‐bond preparation [DOI]
12. 12 Identification of reaction products between drug substances and excipients by HPLC–SPE–NMR: Ester and amide formation between citric acid and 5-aminosalicylic acid [DOI]
13. 13 Voltammetric studies of 2-hydroxy-5-[(4-sulfophenyl)azo]benzoic acid as a novel prodrug of 5-aminosalicylic acid [DOI]
14. 14 Absorption kinetics of 5-aminosalicylic acid in rat: influence of indomethacin-induced gastrointestinal lesions and Escherichia Coli Nissle 1917 medication.
15. 15 The application of LC–NMR and LC–MS for the separation and rapid structure elucidation of an unknown impurity in 5-aminosalicylic acid [DOI]
16. 16 Experimental Goettingen minipig and beagle dog as two species used in bioequivalence studies for clinical pharmacology (5-aminosalicylic acid and atenolol as model drugs).
17. 17 LC-MS/MS and FT-IR analyses of stones from a patient with Crohn’s disease: a case report [DOI]
18. 18 Determination of impurities in the drug 5-aminosalicylic acid by micellar electrokinetic capillary chromatography using an electrolyte pH that approaches the isoelectric point of the parent compound [DOI]
19. 19 Assay of 5-aminosalicylate and its acetylated metabolite in biological fluids by high-performance liquid chromatography on dynamically modified silica [DOI]
20. 20 Simplified high-performance liquid chromatographic method for 5-amino-salicylic acid in plasma and urine [DOI]
21. 21 Pharmacokinetics of a 5‐aminosalicylic acid enteric‐coated tablet in patients with Crohn's disease or ulcerative colitis and in healthy volunteers [DOI]
22. 22 Comparative pharmacokinetics of equimolar doses of 5‐aminosalicylate administered as oral mesalamine (Asacol) and balsalazide: a randomized, single‐dose, crossover study in healthy volunteers1 [DOI]
23. 23 High-performance liquid chromatographic assay for the determination of 5-aminosalicylic acid and acetyl-5-aminosalicylic acid concentrations in endoscopic intestinal biopsy in humans [DOI]
24. 24 Simple and sensitive high-performance liquid chromatographic assay for 5-aminosalicylic acid and acetyl-5-aminosalicylic acid in serum [DOI]
25. 25 Investigation of the stability of 5-aminosalicylic acid in tablets and suppositories by high-performance liquid chromatography [DOI]
26. 26 Chemistry, Pharmacology, Pharmacokinetics, and Clinical Applications of Mesalamine for the Treatment of Inflammatory Bowel Disease [DOI]
27. 27 High-performance liquid chromatographic assay of 5-aminosalicylic acid and its acetylated metabolite in biological fluids using electrochemical detection [DOI]
28. 28 Bioavailability of single and multiple doses of a new oral formulation of 5‐ASA in patients with inflammatory bowel disease and healthy volunteers [DOI]
29. 29 Bioavailability of Single and Multiple Doses of Enteric-Coated Mesalamine and Sulphasalazine [DOI]
30. 30 Ion-pairing high-performance liquid chromatographic method for the determination of 5-aminosalicylic acid and related impurities in bulk chemical [DOI]
31. 31 Pharmacokinetics and safety of single and multiple doses of Asacol tablets in Japanese healthy volunteers [DOI]
32. 32 Mono- and Biphasic Plasma Concentration-time Curves of Mesalazine from a 500 mg Suppository in Healthy Male Volunteers Controlled by the Time of Defecation before Dosing [DOI]
33. 33 Simultaneous determination of 5-aminosalicylic acid and 5-acetylaminosalicylic acid by high-performance liquid chromatography [DOI]
34. 34 [Study on the analysis of zinc 5-aminosalicylate and related compounds by high performance liquid chromatography].

Cited by 16

Showing 8 of 16 known citations — external sources report more than can currently be individually listed.

Related research

• An In-silico Pharmacokinetics Study on Cis-Heptadeca-1,9-Diene-4,6-Diyne-3,8-Diol: A Nutraceutical Compound with Anticancer Properties — shares topic coverage
• Development and Validation of Bio Analytical Method for Estimation of Bortezomib in k3 EDTA Human Plasma Using HPLC-ESI-MS/MS and Its Application to a Bioequivalence & CME Studies — shares topic coverage
• Drug Metabolism and Disposition in Australian Marsupial Koala (Phascolarctos cinereus) — shares topic coverage
• Ochnaflavone, a Naturally Occuring Biflavonoid: Pharmacology and Prospects for Future Research — shares topic coverage
• The Frequency of CYP3A5 Expression in a Mexican Population Compared to a Caucasian Population — shares topic coverage